No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Truist Financial Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating
Truist Removes Price Target From Sangamo Therapeutics, Keeps Buy Rating; Price Target Had Been $5
Lacklustre Performance Is Driving Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) 28% Price Drop
Wells Fargo Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating, Maintains Target Price $2
Jefferies Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Cuts Target Price to $2
RBC Capital Reiterates Sector Perform on Sangamo Therapeutics, Maintains $2 Price Target
